Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this crucial final discussion on the current scenario of cancer. The field of oncology is in the midst of a transformative era, driven by the profound importance of genomic testing and remarkable advancements in both diagnosis and treatment. In the past, cancer was often categorized by its anatomical location, leading to a "one-size-fits-all" approach. However, with the integration of cutting-edge technologies, we can now precisely identify the unique molecular and genetic drivers of each patient's tumor. This shift toward personalized medicine has enabled the development of highly effective targeted therapies and immunotherapies, which offer superior outcomes and fewer side effects compared to traditional cytotoxic chemotherapy.
The central pillar of this revolution is genomic testing, which provides a detailed blueprint of a tumor's genetic makeup. By identifying specific mutations, fusions, or other genomic alterations, clinicians can select treatments that directly target these abnormalities. This not only enhances therapeutic efficacy but also helps predict treatment resistance and informs clinical trial eligibility. Furthermore, advancements in diagnostic techniques, such as liquid biopsies and next-generation sequencing, are making it possible to detect cancer at earlier stages and monitor treatment response with unprecedented accuracy. This empowers healthcare providers to make more informed decisions, ensuring each patient receives the most appropriate and advanced care available.
Therefore, join Dr. Poonam Patil for this final discussion to gain a comprehensive understanding of how genomic testing is reshaping the current scenario of cancer care. Listen to the expert insights, grasp the shared knowledge on advancements in diagnosis and treatment, and continue to follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975
2.
Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.
3.
Interleukin-6 may boost prediction of obesity-related cancers
4.
Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.
5.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
1.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
2.
Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies
3.
HCC Codes in Oncology: Care Optimization in Plexiform Neurofibroma Management
4.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
5.
Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
5.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation